WO2013171446A2 - Saliva testing - Google Patents
Saliva testing Download PDFInfo
- Publication number
- WO2013171446A2 WO2013171446A2 PCT/GB2013/000226 GB2013000226W WO2013171446A2 WO 2013171446 A2 WO2013171446 A2 WO 2013171446A2 GB 2013000226 W GB2013000226 W GB 2013000226W WO 2013171446 A2 WO2013171446 A2 WO 2013171446A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pad
- sample
- test
- saliva
- filter pad
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B2010/0003—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person
Definitions
- the present invention relates to devices and methods for carrying out assays on saliva samples and in particular to lateral flow devices and methods.
- Lateral flow devices are used in assays and are simple devices intended to detect the presence (or absence) of a target in a sample.
- the lateral flow devices may be used in a wide variety of applications including pregnancy tests, HIV tests and malaria tests.
- the test can be applied to ,for instance, urine, saliva, blood or stool samples.
- EP1277053 discloses a method and device for diagnostic testing of an oral fluid, including saliva. This patent is concerned with a problem encountered with the testing of saliva which is that the saliva sample does not run along the lateral flow test strip. The inventors of EP 1277053 believed that this was due to the relatively high concentrations of mucin and other viscous, proteinaceous materials in the specimen. The inventors proposed including in the device a pad having deposited thereon a salt or other known mucinolytic substance known to break down and lower the viscosity of mucin-containing fluids. The pad is composed of a glass of fibre matrix which provides means for filtering the disassociated proteinaceous and other particulate material from the specimen. The device is stated to allow convenient and rapid testing of a relatively small saliva sample without any need to pre-treat the saliva in order to enable its migration along the test strip.
- the fibre pad specified in EP1277053 comprises a die-cut portion of a commercially available glass fibre material having a thickness of about 0.2 mm.
- the pad is placed on a conjugate pad which has a detector reagent deposited thereon.
- the saliva specimen is placed on the glass fibre salt pad which breaks down mucin substances which are subsequently filtered by the glass fibres in the salt pad as well as in the underlying glass fibre sample pad.
- the specimen sample then passes through the conjugate pad where a chemical reaction begins if the analyte is present in the specimen.
- the specimen sample then passes into capture zones where the test result can be read.
- the inventors of the present invention have discovered that, for the purposes of certain saliva assays, including a pepsin assay, the saliva runs along the lateral flow test strip sufficiently well to enable test results to be obtained. However in perhaps about 10% of tests the saliva does not run sufficiently well. The reason for this is not clear. However the inventors have discovered that the use of a relatively thick filter, compared to that suggested in EP1277053, enables the saliva to run sufficiently well for meaningful test results to be obtained. Accordingly it is not necessary to have the saliva pass through a pad which is loaded with a material capable of dissociating proteinaceous materials, for example, a salt.
- a device for testing an oral fluid such as saliva comprising an absorbent lateral flow test strip having a sample portion for receiving a sample to be tested and a test portion for visualising the test results, the sample portion including a filter pad through which, in use the saliva passes before reaching the test portion, the filter pad having a thickness of at least 0.5 mm.
- the present invention also provides a method for carrying out a diagnostic test of an oral fluid specimen, the method comprising providing a device as claimed in any of the preceding claims, depositing an oral fluid specimen on the sample portion and visualising the test results provided on the test portion.
- the device includes a housing accommodating a diagnostic strip providing said sample and test portion.
- the sample portion is located at one end of the diagnostic strip.
- an absorbent portion is located at the other end of the diagnostic strip.
- the filter pad is a binder-free fibre pad. More preferably the fibre pad is a glass fibre pad, most preferably a micro-glass pad.
- the fibre pad is formed from a borosilicate micro-glass.
- the sample portion includes a backing substrate to which the fibre pad is adhered.
- the backing substrate is an adhesive polystyrene.
- the thickness of the filter pad is at least 0.7 mm, more preferably between 0.75 mm and 1 mm.
- Figure 1 shows two lateral flow devices (LFD), the upper LFD not including a filter pad and the lower LFD including a filter pad; and
- FIG. 2 shows LFDs as in Figure 1 but without their housings.
- lateral flow devices 1 comprise a lateral flow assay housed within a plastic housing 3 including a sample well 5 for receiving a saliva specimen.
- a diagnostic strip 7 accommodated within the housing comprises a sample reception portion, a test portion for visualising the test results and an absorbent portion at the end remote from the sample reception portion.
- a binder-free borosilicate micro-glass fibre pad is located directly beneath the sample well 5 and adhered to an adhesive polystyrene backing substrate.
- the micro-glass fibre pad has a basis weight of 120.4 gm 2 , a thickness 0.85 mm and a Frazier permeability of 75.2 L/m 2 /sec.
- An example of a suitable fibre pad is a Grade 142 pad made by Ahlstrom.
- the fibre pad facilitates the slow filtration, transition and migration of the sample to the adjacent glass fibre conjugate pad, with which it is in communication.
- the resultant "treated" saliva rehydrates the immobilised polystyrene labels following which there is migration to the nitrocellulose membrane test region.
- any particulates are filtered out by sized selection. Transition of other salivary components is regulated and the treated sample is slowly and consistently released on to the conjugate pad. Upon transition to the test region and ultimately the absorbent zone, the saliva is drawn through by continued capillary action. It is believed that the pad sufficiently modities the sample such that those of "problematic" individuals are regulated to behave and therefore flow through the interstitial spaces of the membranes in the same manner as for a "non-problematic" specimen, resulting in identical assay performance.
- Figure 1 shows the results of an assay of the saliva of a "problematic" specimen. It can be seen that, in the other LFD, no control line appears in the window 7. In Figure 2, which shows the same LFDs but with the housings removed, it can be seen that, in the upper LFD, the 80 ⁇ saliva sample has agglutinated and not flowed.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1422440.6A GB2518311B (en) | 2012-05-17 | 2013-05-17 | Saliva testing |
CN201380025829.0A CN104471399B (en) | 2012-05-17 | 2013-05-17 | Device for saliva testing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1208663.3A GB201208663D0 (en) | 2012-05-17 | 2012-05-17 | Saliva testing |
GB1208663.3 | 2012-05-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013171446A2 true WO2013171446A2 (en) | 2013-11-21 |
WO2013171446A3 WO2013171446A3 (en) | 2014-01-09 |
Family
ID=46458970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2013/000226 WO2013171446A2 (en) | 2012-05-17 | 2013-05-17 | Saliva testing |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN104471399B (en) |
GB (2) | GB201208663D0 (en) |
WO (1) | WO2013171446A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1277053A1 (en) | 2000-04-19 | 2003-01-22 | Varian, Inc. | Device and process for lateral flow saliva testing |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI92882C (en) * | 1992-12-29 | 1995-01-10 | Medix Biochemica Ab Oy | Disposable test strip and process for its manufacture |
WO2000007015A1 (en) * | 1998-07-29 | 2000-02-10 | Syntron Bioresearch, Inc. | Immunoassay device |
AU2002225017B2 (en) * | 2001-01-15 | 2006-07-06 | Dsm Ip Assets B.V. | Test device |
US7772007B2 (en) * | 2004-04-02 | 2010-08-10 | Cholestech Corporation | Assay device for direct measurement of LDL cholesterol |
EP1758448A4 (en) * | 2004-06-02 | 2009-11-04 | Relia Diagnostic Systems Llc | Quantitative lateral flow system and assay |
-
2012
- 2012-05-17 GB GBGB1208663.3A patent/GB201208663D0/en not_active Ceased
-
2013
- 2013-05-17 WO PCT/GB2013/000226 patent/WO2013171446A2/en active Application Filing
- 2013-05-17 GB GB1422440.6A patent/GB2518311B/en active Active
- 2013-05-17 CN CN201380025829.0A patent/CN104471399B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1277053A1 (en) | 2000-04-19 | 2003-01-22 | Varian, Inc. | Device and process for lateral flow saliva testing |
Also Published As
Publication number | Publication date |
---|---|
CN104471399B (en) | 2017-05-03 |
WO2013171446A3 (en) | 2014-01-09 |
GB2518311A (en) | 2015-03-18 |
GB2518311B (en) | 2016-05-11 |
GB201208663D0 (en) | 2012-06-27 |
CN104471399A (en) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6372513B1 (en) | Device and process for lateral flow saliva testing | |
US5981294A (en) | Device for blood separation in a diagnostic device | |
EP0556202B1 (en) | Improved ligand assay | |
US5423989A (en) | Plasma forming device | |
US4526690A (en) | Apparatus for nucleic acid quantification | |
JPH0664051B2 (en) | Blood separation apparatus and method | |
US20170212108A1 (en) | Device for rapid diagnostic tests to detect antigens with improved sensitivity | |
AU2009264774A1 (en) | Porous solid phase for binding assay, and binding assay method using the same | |
CN111077309B (en) | Immunoassay with capture conjugate | |
ATE421095T1 (en) | POROSITY AND BIOLOGICAL ACTIVITY MAINTAINING ADHESIVE MEMBRANES IN AN ASSAY DEVICE FOR MEASUREMENT OF SERUM CHOLESTEROL IN ASSOCIATION WITH HIGH DENSITY LIPOPROTEINS | |
WO2016031892A1 (en) | Immunochromatography test strip | |
WO2005079420A2 (en) | Chromatographic exclusion agglutination assay and methods of use thereof | |
WO2011014673A1 (en) | Automated lateral flow immunoassay cassette with improved flow properties | |
WO2017024297A1 (en) | Multiplexed detection on microfluidic analytical devices | |
US20170212112A1 (en) | Integration of sample separation with rapid diagnostic tests for improved sensitivity | |
WO2013171446A2 (en) | Saliva testing | |
CN204807462U (en) | Saliva sample chemical examination device | |
JP3560934B2 (en) | Method and apparatus for separating plasma or serum from whole blood | |
JP4199607B2 (en) | Immunochromatography test kit and immunochromatography test method | |
AU2001253291B2 (en) | Device and process for lateral flow saliva testing | |
EP3427049A1 (en) | An assay and kit for detection of endotoxin | |
US20210199547A1 (en) | Methods and devices for hydrogel- and aerogel-based sample pretreatment | |
JP3544968B2 (en) | Human hemoglobin detector | |
CN118202245A (en) | Agglutinating agents, devices and methods for whole blood assays | |
AU2001253291A1 (en) | Device and process for lateral flow saliva testing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13733027 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 1422440 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20130517 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1422440.6 Country of ref document: GB |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13733027 Country of ref document: EP Kind code of ref document: A2 |